Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Thermo Fisher Scientific Inc Issues FY 2013 Guidance In Line With Analysts' Estimates


Thursday, 31 Jan 2013 06:00am EST 

Thermo Fisher Scientific Inc announced that it is initiating adjusted EPS and revenue guidance for fiscal 2013. The Company expects to achieve adjusted EPS in the range of $5.32-$5.46 and revenue in the range of $12.80-$13.00 billion for fiscal 2013. The 2013 guidance does not include any future acquisitions or divestitures and is based on current foreign exchange rates. In addition, the adjusted EPS estimate excludes amortization expense for acquisition-related intangible assets and certain other items detailed later in this press release under the heading "Use of Non-GAAP Financial Measures. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $12.94 billion and EPS of $5.43 for fiscal 2013. 

Company Quote

117.15
-0.69 -0.59%
10 Jul 2014